Vpcir
1 known investors
VPCIR develops non-invasive lateral flow diagnostic test sticks that detect living pathogens in saliva, using patented Rolling Circle Amplification technology for point-of-care Tuberculosis testing. Its pipeline extends to other infectious diseases such as Malaria, targeting affordable, accessible diagnostics for global healthcare.
Investors · 1
Frequently asked questions
- What does Vpcir do?
- VPCIR develops non-invasive lateral flow diagnostic test sticks that detect living pathogens in saliva, using patented Rolling Circle Amplification technology for point-of-care Tuberculosis testing. Its pipeline extends to other infectious diseases such as Malaria, targeting affordable, accessible diagnostics for global healthcare.
- Who are Vpcir's investors?
- Vpcir's investors include Seier Capital.